- Home
- ETNB vs ADSE Comparison
ETNB vs ADSE Comparison
Compare ETNB & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- ADSE
- Stock Information
- Founded
- ETNB 2018
- ADSE 1980
- Country
- ETNB United States
- ADSE Ireland
- Employees
- ETNB 93
- ADSE N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- ADSE Industrial Specialties
- Sector
- ETNB Health Care
- ADSE Consumer Discretionary
- Exchange
- ETNB Nasdaq
- ADSE Nasdaq
- Market Cap
- ETNB 1.2B
- ADSE 777.7M
- IPO Year
- ETNB 2019
- ADSE N/A
- Fundamental
- Price
- ETNB $8.18
- ADSE $14.05
- Analyst Decision
- ETNB Strong Buy
- ADSE Hold
- Analyst Count
- ETNB 9
- ADSE 1
- Target Price
- ETNB $29.63
- ADSE $14.00
- AVG Volume (30 Days)
- ETNB 1.5M
- ADSE 128.3K
- Earning Date
- ETNB 05-08-2025
- ADSE 04-29-2025
- Dividend Yield
- ETNB N/A
- ADSE N/A
- EPS Growth
- ETNB N/A
- ADSE N/A
- EPS
- ETNB N/A
- ADSE N/A
- Revenue
- ETNB N/A
- ADSE $158,974,606.00
- Revenue This Year
- ETNB N/A
- ADSE $101.72
- Revenue Next Year
- ETNB N/A
- ADSE $55.77
- P/E Ratio
- ETNB N/A
- ADSE N/A
- Revenue Growth
- ETNB N/A
- ADSE 168.42
- 52 Week Low
- ETNB $5.99
- ADSE $9.52
- 52 Week High
- ETNB $13.71
- ADSE $16.35
- Technical
- Relative Strength Index (RSI)
- ETNB 42.49
- ADSE 39.26
- Support Level
- ETNB $6.88
- ADSE $13.80
- Resistance Level
- ETNB $9.40
- ADSE $14.88
- Average True Range (ATR)
- ETNB 0.66
- ADSE 0.77
- MACD
- ETNB -0.22
- ADSE -0.06
- Stochastic Oscillator
- ETNB 30.27
- ADSE 35.19
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services which enable the customer to control and manage the system. Geographically, it derives a majority of its revenue from Europe.